NCT06993922 Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block Versus Bupivacaine Alone for Postoperative Pain Management in Patients Undergoing Craniotomy
| NCT ID | NCT06993922 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Dexmedetomidine |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-05-29 |
| Primary Completion | 2025-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-05-29 with a primary completion date of 2025-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare dexmedetomidine as an adjuvant to bupivacaine in scalp block versus bupivacaine alone for postoperative pain management in patients undergoing craniotomy.
Eligibility Criteria
Inclusion Criteria: * Age from 18 to 65 years. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I or II. * Undergoing supratentorial elective planned craniotomies. Exclusion Criteria: * Patients refusal. * History of known allergy to the used local anesthetic or dexmedetomidine. * Bleeding disorders. * Evidence of local infection at the site of injection. * Emergency craniotomy. * Psychotic disorder. * Patients who will not be extubated in the operating room after surgery.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06993922 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Dexmedetomidine. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06993922 currently recruiting?
Yes, NCT06993922 is actively recruiting participants. Contact the research team at Omar-Ahmed@med.asu.edu.eg for enrollment information.
Where is the NCT06993922 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06993922 clinical trial?
NCT06993922 is sponsored by Ain Shams University. The trial plans to enroll 50 participants.